Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
9.02
+2.17 (31.68%)
At close: Mar 9, 2026, 4:00 PM EDT
9.24
+0.22 (2.44%)
After-hours: Mar 9, 2026, 7:12 PM EDT
Cartesian Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 235 | 187 | 461 | 107 | - | - |
| Market Cap Growth | -53.51% | -59.31% | 330.61% | - | - | - |
| Enterprise Value | 109 | 57 | 256 | - | - | - |
| Last Close Price | 6.85 | 7.21 | 17.91 | 20.68 | - | - |
| PS Ratio | 79.12 | 67.03 | 11.84 | 4.12 | - | - |
| PB Ratio | - | -1.48 | -67.74 | -0.77 | - | - |
| EV/Sales Ratio | 38.91 | 20.27 | 6.58 | - | - | - |
| Debt / Equity Ratio | -0.10 | -0.10 | -2.06 | -0.08 | 0.40 | 0.18 |
| Debt / EBITDA Ratio | - | - | - | - | 2.01 | - |
| Net Debt / Equity Ratio | 0.89 | 0.89 | 29.20 | 0.47 | -1.03 | -0.50 |
| Net Debt / EBITDA Ratio | 1.34 | 1.34 | 5.78 | 0.90 | -6.11 | 1.03 |
| Net Debt / FCF Ratio | 1.42 | 1.42 | 6.06 | 1.28 | 2.95 | 0.06 |
| Asset Turnover | 0.01 | 0.01 | 0.11 | 0.11 | 1.26 | - |
| Quick Ratio | 8.45 | 8.45 | 9.29 | 1.26 | 5.76 | 6.38 |
| Current Ratio | 8.65 | 8.65 | 9.43 | 1.33 | 5.91 | 6.42 |
| Return on Equity (ROE) | - | - | - | - | 70.21% | - |
| Return on Assets (ROA) | -14.82% | -14.82% | -6.00% | -19.75% | 10.35% | - |
| Return on Capital Employed (ROCE) | -30.80% | -30.80% | -8.60% | -31.40% | 10.30% | -54.70% |
| Earnings Yield | -58.88% | -69.50% | -16.80% | -205.34% | - | - |
| FCF Yield | -35.88% | -42.35% | -7.11% | -48.01% | - | - |
| Buyback Yield / Dilution | -49.63% | -49.63% | -235.72% | -6.33% | -27.59% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.